AQR CAPITAL MANAGEMENT LLC - 31 Mar 2025 SCHEDULE 13G/A Report for Translational Development Acquisition Corp. Class A ordinary shares, $0.0001 par value per share (TDAC)

Filing Manager
AQR CAPITAL MANAGEMENT LLC
Reporting Manager
AQR Capital Management, LLC
Security
Translational Development Acquisition Corp. Class A ordinary shares, $0.0001 par value per share
Symbol
TDAC
Shares outstanding
17,241,207 shares
Disclosed Ownership
1,099,989 shares
Ownership
6.4%
Form type
SCHEDULE 13G/A
Filing time
14 May 2025, 12:33:36 UTC
Date of event
31 Mar 2025
Previous filing
14 Feb 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"AQR CAPITAL MANAGEMENT LLC disclosed 6.4% ownership in Translational Development Acquisition Corp. Class A ordinary shares, $0.0001 par value per share (TDAC) on 31 Mar 2025."

Quick Takeaways

  • AQR CAPITAL MANAGEMENT LLC filed SCHEDULE 13G/A for Translational Development Acquisition Corp. Class A ordinary shares, $0.0001 par value per share (TDAC).
  • Disclosed ownership: 6.4%.
  • Date of event: 31 Mar 2025.

What Changed

  • Previous schedule filing date: 14 Feb 2025.
  • Current filing was accepted on 14 May 2025, 12:33.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
AQR Capital Management, LLC 6.4% 1,099,989 0 1,099,989 Henry Parkin Authorized Signatory
AQR Capital Management Holdings, LLC 6.4% 1,099,989 0 1,099,989 Henry Parkin Authorized Signatory
AQR Arbitrage, LLC 6.4% 1,099,989 0 1,099,989 Henry Parkin Authorized Signatory

Sponsored